|
DE2965655D1
(en)
|
1978-06-28 |
1983-07-21 |
Beecham Group Plc |
Secondary amines, their preparation, pharmaceutical compositions containing them and their use
|
|
ATE1899T1
(de)
|
1979-06-16 |
1982-12-15 |
Beecham Group Plc |
Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
|
|
US4338333A
(en)
|
1979-06-16 |
1982-07-06 |
Beecham Group Limited |
Ethanamine derivatives their preparation and use in pharmaceutical compositions
|
|
PT82120B
(en)
|
1985-03-01 |
1988-06-16 |
Beecham Group Plc |
Process for preparing veterinary formulations containing ethanolamine derivatives
|
|
GB8528633D0
(en)
|
1985-11-21 |
1985-12-24 |
Beecham Group Plc |
Compounds
|
|
IT1204416B
(it)
|
1986-06-27 |
1989-03-01 |
Midy Spa |
Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
|
|
GB8801306D0
(en)
|
1988-01-21 |
1988-02-17 |
Ici Plc |
Chemical compounds
|
|
EP0403360B1
(fr)
|
1989-06-13 |
1996-10-16 |
Sanofi |
Utilisation de phényléthanolamines pour la préparation de médicaments pour les affections oculaires
|
|
GB8925032D0
(en)
|
1989-11-06 |
1989-12-28 |
Ici Plc |
Chemical compounds
|
|
US5061727A
(en)
|
1990-05-04 |
1991-10-29 |
American Cyanamid Company |
Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
|
|
ES2139633T3
(es)
|
1992-08-31 |
2000-02-16 |
Sankyo Co |
Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica.
|
|
US5578638A
(en)
|
1993-11-05 |
1996-11-26 |
American Cyanamid Company |
Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
|
|
US5776983A
(en)
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
IL113084A
(en)
|
1994-03-23 |
1999-01-26 |
Sankyo Co |
Thiazolidine and oxazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
|
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
|
US5561142A
(en)
|
1994-04-26 |
1996-10-01 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
|
|
DE69521529T2
(de)
|
1994-11-29 |
2001-10-11 |
Dainippon Pharmaceutical Co., Ltd. |
Indolderivat
|
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
|
DK0764632T3
(da)
|
1995-09-21 |
2001-09-24 |
Lilly Co Eli |
Selektive beta3-adrenerge agonister
|
|
ZA967892B
(en)
|
1995-09-21 |
1998-03-18 |
Lilly Co Eli |
Selective β3 adrenergic agonists.
|
|
WO1997015549A1
(en)
|
1995-10-26 |
1997-05-01 |
Tokyo Tanabe Company Limited |
PHENYLETHANOLAMINE COMPOUNDS USEFUL AS β3 AGONIST, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATES IN THE PRODUCTION OF THE SAME
|
|
CN1083831C
(zh)
|
1996-01-10 |
2002-05-01 |
旭化成株式会社 |
新的三环化合物及含有它们的药物组合物
|
|
US5770615A
(en)
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
EP0801060A1
(en)
|
1996-04-09 |
1997-10-15 |
Pfizer Inc. |
Heterocyclic Beta-3 Adrenergenic Agonists
|
|
WO1997046556A1
(en)
|
1996-06-07 |
1997-12-11 |
Merck & Co., Inc. |
OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
|
|
ES2171839T3
(es)
|
1996-09-05 |
2002-09-16 |
Lilly Co Eli |
Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
|
|
ID22273A
(id)
|
1997-01-28 |
1999-09-23 |
Merck & Co Inc |
TIAZOL BENZENASULFONAMIDA SEBAGAI AGONIS β UNTUK PENGOBATAN DIABETES DAN OBESITAS
|
|
ES2149742T1
(es)
|
1997-07-03 |
2000-11-16 |
Asahi Chemical Ind |
Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos.
|
|
EP1303509B1
(en)
|
2000-07-13 |
2012-11-28 |
Eli Lilly And Company |
Beta3 adrenergic agonists
|
|
US6537994B2
(en)
|
2000-07-17 |
2003-03-25 |
Wyeth |
Heterocyclic β3 adrenergic receptor agonists
|
|
US20040242485A1
(en)
|
2003-05-30 |
2004-12-02 |
Takashi Kadowaki |
Compositions and methods for the amelioration of leptin resistance
|
|
DK3459558T3
(da)
*
|
2010-06-25 |
2020-11-02 |
Univ Aston |
Glycoproteiner med lipidmobiliserende egenskaber og terapeutiske anvendelser deraf
|
|
CN102764438A
(zh)
*
|
2012-01-30 |
2012-11-07 |
林曙光 |
β3肾上腺素受体激动剂的新用途
|